<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20140222016680N8</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-05-14</date_registration>
      <primary_sponsor>Iran University of Medical Sciences</primary_sponsor>
      <public_title>The effect of exercise therapy with ball in children with cerebral palsy</public_title>
      <acronym></acronym>
      <scientific_title>The effect of exercise therapy with Swiss ball on the trunk control and balance in children with spastic cerebral palsy</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-08-01</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/55541</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Stratification and Random blocks with four blocks will be used for randomization. The randomization type using the stratification method will be performed in four classes: cerebral palsy type of diplegia and hemiplegia, the age range between 6 to 9 years and 9 to 12 years using 4 blocks. For concealment in the randomization process, a unique code will be used on each envelope, Blinding description: In this study ,Assessor who evaluates the outcome measures of study and the participants in the study will be blind to the allocation of the two treatment groups. Additionally the data also will be evaluated by a person who is blind to the allocation and treatment of groups.</study_design>
      <phase>N/A</phase>
      <hc_freetext>spastic cerebral palsy.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: In this group, exercises with Swiss ball, will be given in a period of 5 weeks, three sessions per week. Each treatment session starts with warming up and then special exercises are given with focus on improving trunk control in supine, prone, sitting, quadruped and standing positions and then it ends with cooling down. Each treatment session, depending on the patient needs to rest, lasts approximately 45 minutes. Required equipment are mats and gymnastics ball. Trunk control score, pediatric balance score, gross motor function score, functional mobility score, abdominal muscle thickness(internal oblique, external oblique and transverse abdomen ) at rest and hip flexion will be measured before the intervention, the last session of treatment and one month after the end of intervention. Intervention 2: Control group: Intervention group: In this group,  trunk control exercises on floor, will be given in a period of 5 weeks, three sessions per week. Each treatment session starts with warming up and then conventional exercises are given with focus on improving trunk control in supine, prone, sitting, quadruped and standing positions and then it ends with cooling down. Each treatment session, depending on the patient needs to rest, lasts approximately 45 minutes. Required equipment are mats and chairs. Trunk control score, pediatric balance score, gross motor function score, functional mobility score, abdominal muscle thickness(internal oblique, external oblique and transverse abdomen ) at rest and hip flexion will be measured before the intervention, the last session of treatment and one month after the end of intervention.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no further information.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Shohreh Noorizadeh Dehkordi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Rehabilitation Sciences, Madadkaran Street, Shahnazari Street, Madar Square, Mirdamad, Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>15459-13487</zip>
        <telephone>+98 21 2222 7124</telephone>
        <email>noorizadeh.sh@iums.ac.ir</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Shohreh Noorizadeh Dehkordi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Rehabilitation Sciences, Madadkaran Street, Shahnazari Street, Madar Square, Mirdamad, Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>15459-13487</zip>
        <telephone>+98 21 2222 7124</telephone>
        <email>noorizadeh.sh@iums.ac.ir</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Have a diagnosis of spastic diplegia / hemiplegia as determined by a pediatric neurologist
Having age range between 6 and 12 years old
Having motor function at levels between 1 and 3  based on the "Gross Motor Function Classification Scale"
Ability to understand and follow verbal instructions
No severe visual or hearing impairment
Having a score above 70 in the "SPARCLE "questionnaire
Ability to active straight leg raise and maintain it when the ultrasound instrument records the abdominal muscle image</inclusion_criteria>
      <agemin>6 years</agemin>
      <agemax>12 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Having a seizure is not controlled
Having a body mass index above 25 due to reduced reliability of ultrasonography images</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G80</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Cerebral palsy</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In this group, exercises with Swiss ball, will be given in a period of 5 weeks, three sessions per week. Each treatment session starts with warming up and then special exercises are given with focus on improving trunk control in supine, prone, sitting, quadruped and standing positions and then it ends with cooling down. Each treatment session, depending on the patient needs to rest, lasts approximately 45 minutes. Required equipment are mats and gymnastics ball. Trunk control score, pediatric balance score, gross motor function score, functional mobility score, abdominal muscle thickness(internal oblique, external oblique and transverse abdomen ) at rest and hip flexion will be measured before the intervention, the last session of treatment and one month after the end of intervention.</i_keyword>
      <i_keyword>Control group: Intervention group: In this group,  trunk control exercises on floor, will be given in a period of 5 weeks, three sessions per week. Each treatment session starts with warming up and then conventional exercises are given with focus on improving trunk control in supine, prone, sitting, quadruped and standing positions and then it ends with cooling down. Each treatment session, depending on the patient needs to rest, lasts approximately 45 minutes. Required equipment are mats and chairs. Trunk control score, pediatric balance score, gross motor function score, functional mobility score, abdominal muscle thickness(internal oblique, external oblique and transverse abdomen ) at rest and hip flexion will be measured before the intervention, the last session of treatment and one month after the end of intervention.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Trunk control score. Timepoint: Measurement of trunk control before intervention, after intervention and one month after the end of the intervention. Method of measurement: "Trunk Control Measurement Scale".</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Balance score. Timepoint: Before intervention, after intervention and one month after the end of the intervention. Method of measurement: "Pediatric Balance Scale".</sec_outcome>
      <sec_outcome>Gross Motor Function Score. Timepoint: Before intervention, after intervention and one month after the end of the intervention. Method of measurement: Levels of D and E of the "Gross Motor Function Measurement".</sec_outcome>
      <sec_outcome>Functional Mobility Score. Timepoint: Before intervention, after intervention and one month after the end of the intervention. Method of measurement: "Pediatric Evaluation of Disability inventory".</sec_outcome>
      <sec_outcome>Abdominal Muscles Thickness. Timepoint: Before intervention, after intervention and one month after the end of the intervention. Method of measurement: Sonography.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Iran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-04-18</approval_date>
        <contact_name>Ethic committee of Iran University of Medical Sciences</contact_name>
        <contact_address>Iran University of Medical Sciences, Hemmat Expressway, Tehran, Iran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
